Inimex Pharmaceuticals

About:

Inimex Pharmaceuticals is a clinical-stage company focused on the development and commercialization of innate defense regulators.

Website: http://www.inimexpharma.com

Top Investors: BDC Venture Capital, Morningside Group, Roche Venture Fund, Discovery Capital, MDS Capital

Description:

Inimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body's innate defenses without causing inflammation.

Total Funding Amount:

$28.1M

Headquarters Location:

Burnaby, British Columbia, Canada

Founded Date:

2001-01-01

Contact Email:

info(AT)inimexpharma.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2008-06-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai